English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Yourgene Health Launches Insight DPYD Assay (IVDR)
2026-09-09
Original from: Yourgene Health Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the co..
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
2026-09-09
Original from: Labcorp Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and spe..
IVD China last week: Wantai BioPharm, MGI × Yeasen Biotechnology, Mirxes, Yingsheng Bio × Sinopharm
2026-09-08
Wantai BioPharm Launches ISO 15189 Solution for Blood Centers Wantai BioPharm has launched an integrated ISO 15189 solution for blood collection and supply institutions, combining professional consulting..
WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
2026-09-08
Original from: PR Newswire Cepheid, a Danaher company and a leader in molecular diagnostics, today announced that it has received Emergency Use Listing (EUL) from the World Health Organization ..
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer
2026-09-08
Original from: Guardant Health Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx..
Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
2026-09-02
Original from: business wire H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G Nf..
In Vitro Diagnostic Industry in China - Urine X
2026-09-01
2.3.3 AVE-766 Formed Element Analyzer Produced by AVE, it is a new serial of product with machine vision technology, low power screening, positioning, and high-power tracking recognition. 1..
IVD China last week: Roche, Autobio & Comen Medical, Wondfo, Mirxes, Bioperfectus & 3DMed Diagnostics
2026-08-31
Roche Diagnostics’ Elecsys Gastrin 17 Test Approved in China Roche Diagnostics has announced the approval of Elecsys Gastrin 17 (Elecsys G17), a localized innovation developed specifically for the Chine..
Readily Diagnostics receives grant to develop an affordable STI test for low-resource settings
2026-08-31
Original from: Readily Readily Diagnostics AB, a point-of-care diagnostics company founded in 2022 and spun out of Uppsala University, has received a grant of approximately USD 970,000 (about 9 million S..
Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
2026-08-31
Original from: Natera Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new Signatera collaboration with Angiex, Inc., a privately held biotech comp..
Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
2026-08-28
Original from: Quest Diagnostics Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced two new developments for its Quest AD-Detect® portfolio of blood-based bio..
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
2026-08-28
Original from: Agilent Third-quarter fiscal year 2026 - Revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core(1) compared with th..
Stratipath and Aiforia partner to expand access to AI-driven precision diagnostics in oncology
2026-08-27
Original from: Stratipath Stratipath, a leader in AI-based precision diagnostics for breast cancer, and Aiforia, a pioneer in AI-driven diagnostics in pathology, today announced a strategic partnership...
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZITHER
2026-08-27
Original from: PR Newswire Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for expanded use of its PATHWAY® HER2 (4B5) and VENTANA® HER2 Dual ISH DNA Probe Co..
Abbott Receives FDA Authorization For World's First Dual Glucose-Ketone Sensing Technology For People With Diabetes
2026-08-26
Original from: Abbott Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world's first dual glucos..
Total:
3913
Pages:
261
First
Prev
1
2
3
4
5
6
..
261
Next
End